Close Menu

Beckman Coulter

The assays add to the test menu of Beckman Coulter's DxN Veris molecular diagnostics system.

The company lowered its full-year 2015 adjusted EPS estimate on anticipated tougher currency effects.

Core revenues at Beckman Coulter and AB Sciex grew in the mid-single digits during the fourth quarter, CEO Thomas Joyce noted.

The accreditation will help the company's facility move research findings more quickly into the clinical sphere.

Seegene will manufacture reagents designed exclusively for Beckman Coulter's new Veris MDx sample-to-answer molecular diagnostics system.

NEW YORK (GenomeWeb) – Beckman Coulter today announced a collaboration with the University of Birmingham, UK aimed at research into higher-throughput biology.

Biognosys, a swiss proteomics company, said this week that the new version of Spectronaut, its software for analyzing hyper reaction monitoring data, now enables customers automatically generate spectral libraries using search results from Thermo Scientific's Proteome Discoverer platform.

Illumina has launched new reagent kits for the HiSeq X Ten and the HiSeq 2500. Both kits will start shipping in November. The HiSeq X HD v2 reagent kit supports the TruSeq DNA PCR-free sample preparation kit, which eliminates amplification during library preparation.

NEW YORK (GenomeWeb) – Beckman Coulter Life Sciences today announced a deal with New England Biolabs focused on automated methods to improve processes and throughput in next-generation sequencing sample preparation.

Beckman Coulter has been awarded

Pages

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.